Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0296642 METHODS FOR TREATING CARDIAC INJURY
Provided herein are methods for promoting differentiation of cardiac progenitor cells toward myocytes and suppressing the conversion of cardiac progenitor...
2018/0296641 METHOD TO INDUCE NEOVASCULAR FORMATION AND TISSUE REGENERATION
The present invention relates, e.g., to a method for inducing arteriogenesis, lymphangiogenesis, vasculogenesis, or cardiomyogenesis, and/or for inducing...
2018/0296640 Peptides and Method for Treatment of Cardiac Arrest
Modified peptides based on C-terminal PDZ binding domains of PTEN and PHLPP, or PDK1 interacting fragment of PKN2 are described as are methods of using the...
2018/0296639 THERAPEUTIC PEPTIDES
The invention discloses peptides for the treatment and/or prophylaxis of diabetic retinopathy. The peptides of the invention comprise a ...
2018/0296638 COMPOSITIONS FOR TREATING HEART DISEASE BY INHIBITING THE ACTION OF mAKAP-
The present invention provides a method of protecting the heart from damage, by administering to a patient at risk of such damage, a pharmaceutically effective...
2018/0296637 METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF
Disclosed herein are methods and compositions for the diagnosis and treatment of Vascular Associated Maculopathy, or a symptom thereof, in a subject. Disclosed...
2018/0296636 BTNL9 AND ERMAP AS NOVEL INHIBITORS OF THE IMMUNE SYSTEM FOR IMMUNOTHERAPIES
Provided are methods of treating a tumor in a subject with a BTNL9-binding antibody. Also provided are methods of treating a tumor in a subject with an...
2018/0296635 Protein Particles Comprising Disulfide Crosslinkers and Uses Related Thereto
This disclosure relates to particles comprising recombinant proteins, pharmaceutical composition comprising the particles, and therapeutic uses related...
2018/0296634 THERAPY OF ATHEROSCLEROSIS, PRIMARY BILIARY CIRRHOSIS AND NRLP3 INFLAMMASOME-ASSOCIATED DISEASE BY HTCP INHIBITORS
An inhibitor of Na+-taurocholate cotransporting polypeptide (NTCP) for use in a method of treatment of primary biliary cirrhosis, atherosclerosis, or an NRLP3...
2018/0296633 METHOD FOR PREPARING EYE DROPS OF CYCLOSPORIN A
A method for preparing eye drops of cyclosporin A in the form of an emulsion, a microemulsion, or a lipophilic/hydrophilic micellar solution whose...
2018/0296632 USE OF PEPTIDES TO STIMULATE THE IMMUNE SYSTEM
Methods for treating immunodeficiencies are provided using peptide-based compounds.
2018/0296631 HYDROGEL COMPOSITION AND ASSOCIATED METHOD OF USE
The invention provides a composition and pharmaceutical formulation including a peptide immobilized in a hydrogel. Compositions and formulations of the...
2018/0296630 METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS
The disclosure provides methods of preventing or treating ophthalmic diseases or conditions in a mammalian subject. The methods comprise administering an...
2018/0296629 METHOD FOR ISOLATION OF MAO INHIBITORS FROM TEQUILA OR OTHER DISTILLED AGAVE FERMENTATION PRODUCTS
Improved compositions of reversible monoamine oxidase inhibitors are obtained by improved methods of alcohol removal from distillates of fermented agave extracts.
2018/0296628 COMPOSITIONS AND METHODS FOR TREATING TRAVELER'S DIARRHEA
Some embodiments comprise dietary supplements for treating or preventing traveler's diarrhea comprising: (a) about 1000 mg green tea extract comprising at...
2018/0296627 METHOD FOR MODULATING THE EXPRESSION OF THE SREBP-1C, ACC, AND SCD-1 PROTEINS USING LONGAN PERICARP EXTRACT
The present invention provides a method for reducing the expressions of the sterol regulatory element-binding protein 1C (SREBP-1C), acetyl-CoA carboxylase...
2018/0296626 Medicinal composition for prevention or treatment retinal ischemia
This invention relates to a method of preventing or treating a disease, disorder or condition induced by retina ischemia comprising administrating a subject a...
2018/0296625 PHARMACEUTICAL COMPOSITION TREATING SNORING, PREPARATION METHOD THEREFOR AND USE THEREOF
The present invention relates to a pharmaceutical composition for snoring treatment which comprising 15-25 doses of Gambir and 5-15 doses of Cassia....
2018/0296624 PREPARATIONS OF ROSA LAEVIGATA FRUIT EXTRACTS AND USES THEREOF FOR REGULATION OF CD36, APOA1, AND SRB1
Provided is a method of a method of preparing a Rosa laevigata fruit extract which regulates CD36, ApoA1, and SRB1, including extracting the fruit of Rosa...
2018/0296623 PHARMACEUTICAL COMPOSITION FOR PROMOTING PERIODONTAL TISSUE GROWTH AND FOR PREVENTION AND TREATMENT OF...
The present invention relates to a pharmaceutical composition comprising a Magnolia flower extract, a fraction thereof or the compound represented by formula 1...
2018/0296622 DIETARY SUPPLEMENTS FOR TREATING ADHD AND RELATED DISORDERS
Provided herein are compositions, methods of use thereof and kits comprising same for prophylaxis, alleviating or treating a subject with, or experiencing...
2018/0296621 COMPOSITION FOR THE PREVENTION AND/OR TREATMENT OF ALLERGY SYMPTOMS
The present invention relates to a pharmaceutical composition or a food supplement composition and use thereof in the prevention and/or treatment of allergy...
2018/0296620 Treatment of Virus-Based Diseases of the Skin
A method for treatment of virus-based diseases of the skin, in particular, herpes simplex virus type-1 and herpes zoster, which comprises topically...
2018/0296619 Treatment of Virus-Based Diseases of the Skin
A method for treatment of virus-based diseases of the skin, in particular, herpes simplex virus type-1 and herpes zoster, which comprises topically...
2018/0296618 TRADITIONAL CHINESE MEDICINE COMPOSITION HAVING A FUNCTION OF REGULATING EMOTION, A PROCESS FOR PREPARING THE...
The present invention relates to the technical field of health-care product, and in particular relates to a traditional Chinese medicine composition having a...
2018/0296617 APPARATUS FOR PREPARATION OF PHARMACOLOGICALLY-RELEVANT COMPOUNDS FROM BOTANICAL SOURCES
In a system and process for selectively purifying various pharmacologically-relevant components of a source plant such as cannabis, an initial step provides a...
2018/0296616 METHOD FOR PREPARATION OF PHARMACOLOGICALLY-RELEVANT COMPOUNDS FROM BOTANICAL SOURCES
In a multi-step process for selectively purifying various pharmacologically-relevant components of a source plant such as cannabis, an initial step of the...
2018/0296615 PHARMACEUTICAL COMPOSITION OR FUNCTIONAL HEALTH FOOD FOR PREVENTING AND TREATING METABOLIC DISEASES, CONTAINING...
The present invention relates to a composition for preventing and treating metabolic disorders, containing a water extract of Pleurotus eryngii var. ferulea...
2018/0296614 Combination Treatment
Human clinical use of a chimeric poliovirus construct has demonstrated excellent anti-tumor effect. Combination with immune checkpoint inhibitors increases the...
2018/0296613 USE OF AKKERMANSIA MUCINIPHILA FOR TREATING INFLAMMATORY CONDITIONS
The invention relates to use of Akkermansia muciniphila, a mucin-degrading bacterial species found in the human gut, for treating undesirable inflammatory...
2018/0296612 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS
Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable gram negative bacteria and a pharmaceutically...
2018/0296611 Topical Medicament for skin and mucosal injuries
A composition and method for treating Epidermolisis bullosa (EB), comprising: applying to skin or mucosal surfaces of a patient in need of treatment for EB a...
2018/0296610 Methods for Improving Cognition and Slowing Cognitive Impairment
The disclosure is directed to the use of nonviable pluripotent stem cells to improve age-related declines in tissue and organ function. In one aspect,...
2018/0296609 MAPC TREATMENTOF BRAIN INJURIES AND DISEASES
The invention relates to the treatment of various injuries, disorders, dysfunctions, diseases, and the like of the brain with MAPCs, particularly in some...
2018/0296608 Compositions containing SPHEROID CELL AGGREGATES for enhance ovary function and preparation method of the same
The present invention can improve or recover ovarian functions of mammals by containing spheroidal cell aggregates including placenta-derived mesenchymal stem...
2018/0296607 METHODS OF GENERATING MESENCHYMAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS
A method of generating MSCs which secrete neurotrophic factors (NTFs) comprising incubating a population of undifferentiated mesenchymal stem cells (MSCs) in a...
2018/0296606 EXTRACELLULAR VESICLES WITH ENHANCED POTENCY
Provided are methods for isolating potent extracellular vesicle or exosome populations from mesenchymal stromal cells, and the use of the isolated...
2018/0296605 USE OF ALLOGENEIC INTERSTITIAL VESSEL-LAYER CELL AND ALLOGENEIC MESENCHYMAL PROGENITOR CELL FOR PREVENTING OR...
Provided are uses of allogeneic interstitial vessel-layer cells and allogeneic mesenchymal progenitor cells in the preparation of a pharmaceutical composition...
2018/0296604 METHOD FOR TREATMENT OF INFERTILITY, PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFERTILITY AND METHOD FOR...
A pharmaceutical composition contains adipose tissue derived reproductive cells including adipose stem cells, vascular endothelial cells and vascular...
2018/0296603 CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR IMPROVING TRANSPLANTATION
Disclosed herein are compositions and methods for increasing the immunocompatibility of donor cells (e.g., HSCs or T-cells) for transplantation to a recipient...
2018/0296602 METHOD AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY
The present invention provides methods and compositions to confer and/or augment immune responses mediated by cellular immunotherapy, such as by adoptively...
2018/0296601 TREATMENT USING CHIMERIC RECEPTOR T CELLS INCORPORATING OPTIMIZED POLYFUNCTIONAL T CELLS
The disclosure provides methods of treating a malignancy comprising administering an effective dose of a chimeric receptor (e.g., CAR or TCR) genetically...
2018/0296600 TREATMENT OF EPIDERMOLYSIS BULLOSA BY INJECTION OF AUTOLOGOUS COLLAGEN VII OVEREXPRESSING LEUKOCYTES
Methods are provided for the cell-based delivery of collagen VII for the treatment of epidermolysis bullosa.
2018/0296599 TRACE ELEMENT SOLUTION
The invention discloses a trace element solution, which comprises at least the following metals: at least 65 mg/ml zinc directly and/or indirectly from mineral...
2018/0296598 USE OF TRIENTINE TO DELIVER COPPER TO ISCHEMIC TISSUE
Methods of ischemic tissue repair and regeneration through promoting tissue redistribution and reuse of copper by administering a composition comprising a...
2018/0296597 TREATING MALE INFERTILITY SECONDARY TO SPERM OXIDATIVE STRESS
A profertility composition for administration to infertile men with sperm oxidative stress is disclosed. The composition comprises a unique combination of a...
2018/0296596 Antibacterial composition and its use in treating bacterial infections
An antibacterial composition that comprises as active compound at least one light isotope of an element selected from the group which consists of .sup.1H,...
2018/0296595 METHODS AND COMPOSITIONS FOR CANCER TREATMENT
A method for treating leukemia is disclosed. The method comprises administering to a subject with leukemia an effective amount of a pharmaceutical composition...
2018/0296594 SOLID ORAL DOSAGE FORM FOR BREAST SYMPTOMS
The invention is a solid oral dosage form that is designed to deliver a supraphysiological dose of molecular iodine of 3 to 60 mg per day. The solid oral...
2018/0296593 PERITONEAL DIALYSIS FLUID
The present invention is a sterile peritoneal dialysis fluid, including an acidic first liquid containing 60.0 to 94.0 g/L of icodextrin and 0 to 2.34 g/L of...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.